Health

FDA Panel Backs First-in-Class Cholesterol Drug

MATTHEW PERRONE, AP Health Writer GAITHERSBURG, Md. (AP) — Federal health advisers on Tuesday recommended approval for a highly anticipated cholesterol drug from Sanofi and Regeneron Pharmaceuticals, but with the caveat that more data is needed about its long-term ability to reduce heart attacks. The Read More

Advertisements